BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34653601)

  • 1. Copper (Cu) induced changes of lipid metabolism through oxidative stress-mediated autophagy and Nrf2/PPARγ pathways.
    Zhong CC; Zhao T; Hogstrand C; Chen F; Song CC; Luo Z
    J Nutr Biochem; 2022 Feb; 100():108883. PubMed ID: 34653601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophagy mediated carbohydrate-induced changes of lipid metabolism via oxidative stress, endoplasmic reticulum (ER) stress and ChREBP/PPARγ pathways.
    Zhao T; Wu K; Hogstrand C; Xu YH; Chen GH; Wei CC; Luo Z
    Cell Mol Life Sci; 2020 May; 77(10):1987-2003. PubMed ID: 31392349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron increases lipid deposition via oxidative stress-mediated mitochondrial dysfunction and the HIF1α-PPARγ pathway.
    Song CC; Pantopoulos K; Chen GH; Zhong CC; Zhao T; Zhang DG; Luo Z
    Cell Mol Life Sci; 2022 Jul; 79(7):394. PubMed ID: 35786773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAZ deficiency impairs the autophagy-lysosomal pathway through NRF2 dysregulation and lysosomal dysfunction.
    Kim HK; Jeong H; Jeong MG; Won HY; Lee G; Bae SH; Nam M; Lee SH; Hwang GS; Hwang ES
    Int J Biol Sci; 2024; 20(7):2592-2606. PubMed ID: 38725855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARγ alleviates preeclampsia development by regulating lipid metabolism and ferroptosis.
    Lai W; Yu L; Deng Y
    Commun Biol; 2024 Apr; 7(1):429. PubMed ID: 38594496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductive stress in striated muscle cells.
    Bellezza I; Riuzzi F; Chiappalupi S; Arcuri C; Giambanco I; Sorci G; Donato R
    Cell Mol Life Sci; 2020 Sep; 77(18):3547-3565. PubMed ID: 32072237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Protective effect of hygrolansamycin C against corticosterone-induced toxicity and oxidative stress-mediated via autophagy and the MAPK signaling pathway.
    Roh J; Jang JP; Oh T; Kim J; Lee B; Hong YS; Jang JH; Ko SK
    Pharmacol Rep; 2024 Apr; 76(2):435-438. PubMed ID: 38573564
    [No Abstract]   [Full Text] [Related]  

  • 8. Copper homeostasis and cuproptosis in health and disease.
    Chen L; Min J; Wang F
    Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper metabolism in cell death and autophagy.
    Xue Q; Kang R; Klionsky DJ; Tang D; Liu J; Chen X
    Autophagy; 2023 Aug; 19(8):2175-2195. PubMed ID: 37055935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper induces cell death by targeting lipoylated TCA cycle proteins.
    Tsvetkov P; Coy S; Petrova B; Dreishpoon M; Verma A; Abdusamad M; Rossen J; Joesch-Cohen L; Humeidi R; Spangler RD; Eaton JK; Frenkel E; Kocak M; Corsello SM; Lutsenko S; Kanarek N; Santagata S; Golub TR
    Science; 2022 Mar; 375(6586):1254-1261. PubMed ID: 35298263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipophagy mediated glucose-induced changes of lipid deposition and metabolism via ROS dependent AKT-Beclin1 activation.
    Wu LX; Xu YC; Hogstrand C; Zhao T; Wu K; Xu YH; Liu W; Luo Z
    J Nutr Biochem; 2022 Feb; 100():108882. PubMed ID: 34655756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper induces liver lipotoxicity disease by up-regulating Nrf2 expression via the activation of MTF-1 and inhibition of SP1/Fyn pathway.
    Zhong CC; Zhao T; Hogstrand C; Song CC; Zito E; Tan XY; Xu YC; Song YF; Wei XL; Luo Z
    Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166752. PubMed ID: 37182554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
    Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
    Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Copper Homeostasis in Brain Disease.
    An Y; Li S; Huang X; Chen X; Shan H; Zhang M
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy.
    Zheng P; Zhou C; Lu L; Liu B; Ding Y
    J Exp Clin Cancer Res; 2022 Sep; 41(1):271. PubMed ID: 36089608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuproptosis: a copper-triggered modality of mitochondrial cell death.
    Tang D; Chen X; Kroemer G
    Cell Res; 2022 May; 32(5):417-418. PubMed ID: 35354936
    [No Abstract]   [Full Text] [Related]  

  • 17. Copper-induced cell death.
    Kahlson MA; Dixon SJ
    Science; 2022 Mar; 375(6586):1231-1232. PubMed ID: 35298241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molecular Mechanisms of Defective Copper Metabolism in Diabetic Cardiomyopathy.
    Cui X; Wang Y; Liu H; Shi M; Wang J; Wang Y
    Oxid Med Cell Longev; 2022; 2022():5418376. PubMed ID: 36238639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycophagy mediated glucose-induced changes of hepatic glycogen metabolism via OGT1-AKT1-FOXO1
    Wu LX; Xu YC; Pantopoulos K; Tan XY; Wei XL; Zheng H; Luo Z
    J Nutr Biochem; 2023 Jul; 117():109337. PubMed ID: 36990368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cuproptosis: mechanisms and links with cancers.
    Xie J; Yang Y; Gao Y; He J
    Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.